Serrated Lesions of the Colorectum: Review and Recommendations From an Expert Panel
2012/06/19 by Douglas K. Rex, Douglas K Rex, Dennis J. Ahnen +32 · 33 citations
Medicine · #Colorectal Cancer Screening and Detection #Gastric Cancer Management and Outcomes #Genetic factors in colorectal cancer
paper · doi:10.1038/ajg.2012.161
Abstract
Serrated lesions of the colorectum are the precursors of perhaps one-third of colorectal cancers (CRCs). Cancers arising in serrated lesions are usually in the proximal colon, and account for a disproportionate fraction of cancer identified after colonoscopy. We sought to provide guidance for the clinical management of serrated colorectal lesions based on current evidence and expert opinion regarding definitions, classification, and significance of serrated lesions. A consensus conference was held over 2 days reviewing the topic of serrated lesions from the perspectives of histology, molecular biology, epidemiology, clinical aspects, and serrated polyposis. Serrated lesions should be classified pathologically according to the World Health Organization criteria as hyperplastic polyp, sessile serrated adenoma/polyp (SSA/P) with or without cytological dysplasia, or traditional serrated adenoma (TSA). SSA/P and TSA are premalignant lesions, but SSA/P is the principal serrated precursor of CRCs. Serrated lesions have a distinct endoscopic appearance, and several lines of evidence suggest that on average they are more difficult to detect than conventional adenomatous polyps. Effective colonoscopy requires an endoscopist trained in the endoscopic appearance of serrated lesions. We recommend that all serrated lesions proximal to the sigmoid colon and all serrated lesions in the rectosigmoid > 5 mm in size, be completely removed. Recommendations are made for post-polypectomy surveillance of serrated lesions and for surveillance of serrated polyposis patients and their relatives.
Cited by
- ACG Clinical Guidelines: Colorectal Cancer Screening 2021
- Colorectal polypectomy and endoscopic mucosal resection (EMR): European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline
- Quality indicators for colonoscopy
- The proximal serrated polyp detection rate is an easy-to-measure proxy for the detection rate of clinically relevant serrated polyps
- Niccolò IV: il grande mediatore
- Colorectal cancer statistics, 2023
- Real-time differentiation of adenomatous and hyperplastic diminutive colorectal polyps during analysis of unaltered videos of standard colonoscopy using a deep learning model
- Microsatellite Instability and BRAF Mutation Testing in Colorectal Cancer Prognostication
- Serrated polyps of the large intestine: current understanding of diagnosis, pathogenesis, and clinical management. [europepmc]
- Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease. [europepmc]
- Long-term colorectal-cancer incidence and mortality after lower endoscopy. [europepmc]
- Serrated and adenomatous polyp detection increases with longer withdrawal time: results from the New Hampshire Colonoscopy Registry. [europepmc]
- Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer. [europepmc]
- Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression. [europepmc]
- Promoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer. [europepmc]
- ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes. [europepmc]
- Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia. [europepmc]
- Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers. [europepmc]
- Colonoscopy Reduces Colorectal Cancer Incidence and Mortality in Patients With Non-Malignant Findings: A Meta-Analysis. [europepmc]
- Obesity and colorectal cancer: molecular features of adipose tissue. [europepmc]
- Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine. [europepmc]
- Colorectal cancer. [europepmc]
- Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the US Preventive Services Task Force. [europepmc]
- Providing data for serrated polyp detection rate benchmarks: an analysis of the New Hampshire Colonoscopy Registry. [europepmc]
- British Society of Gastroenterology position statement on serrated polyps in the colon and rectum. [europepmc]
- Real-time differentiation of adenomatous and hyperplastic diminutive colorectal polyps during analysis of unaltered videos of standard colonoscopy using a deep learning model. [europepmc]
- Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine. [europepmc]
- Microsatellite instability in colorectal cancer. [europepmc]
- Early-onset colorectal cancer in young individuals. [europepmc]
- Long-term Risk of Colorectal Cancer After Removal of Conventional Adenomas and Serrated Polyps. [europepmc]
- The Molecular Hallmarks of the Serrated Pathway in Colorectal Cancer. [europepmc]
- Colorectal Cancer Screening: An Updated Modeling Study for the US Preventive Services Task Force. [europepmc]
- Differential pre-malignant programs and microenvironment chart distinct paths to malignancy in human colorectal polyps. [europepmc]
Related